Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseLiver TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationKidney TransplantationGraft SurvivalTransplantation ChimeraBone and BonesTissue DonorsAnemia, AplasticLeukemiaBusulfanHematopoietic Stem CellsHistocompatibility TestingHeart TransplantationBone Marrow PurgingTransplantation, IsogeneicHistocompatibilityCyclophosphamideStem Cell TransplantationLung TransplantationGraft RejectionImmunosuppressive AgentsTreatment OutcomeRecurrenceTransplantation ImmunologyCombined Modality TherapyTime FactorsHematopoiesisBone Marrow DiseasesHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationMice, Inbred C57BLOrgan TransplantationT-LymphocytesLeukemia, Myeloid, AcuteRemission InductionImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraGranulocyte Colony-Stimulating FactorRetrospective StudiesBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-HodgkinAcute DiseaseHepatic Veno-Occlusive DiseaseLymphocyte DepletionHematopoietic Stem Cell MobilizationLeukemia, MyeloidSurvival AnalysisGraft vs Host ReactionPancreas TransplantationHLA AntigensLeukocyte TransfusionColony-Forming Units AssayCell TransplantationIslets of Langerhans TransplantationBone RemodelingFlow CytometryCyclosporineBone Marrow NeoplasmsAntigens, CD34TransplantationLeukocyte CountChimeraSevere Combined ImmunodeficiencyLeukocytes, MononuclearAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedMyelodysplastic SyndromesFollow-Up StudiesBlood CellsHematologic DiseasesSurvival RateCord Blood Stem Cell TransplantationCell DifferentiationLymphocyte TransfusionActuarial AnalysisMelphalanMultiple MyelomaCarmustineLymphocytesCytomegalovirus InfectionsNuclear FamilyLiving DonorsCytarabineTransplantation ToleranceDisease-Free SurvivalImmunophenotypingSpleenEtoposideGraft vs Leukemia EffectGraft vs Tumor Effect